Arkolith/Insider Trading/HARP/Form 4

Silvernail Lauren P

DirectorHarpoon Therapeutics, Inc. (HARP) · full profile →Form 4 · filed Mar 11, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2024Disposed to issuer(D)5K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 11, 2024Disposed to issuer(D)2K——0
Mar 11, 2024Disposed to issuer(D)2K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-029447) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML